IGEN Networks (IGEN) 10-K/A 19 Apr 18 2017 FY Annual report (amended) Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2017	Apr. 13, 2018	Jun. 30, 2017
Document And Entity Information
Entity Registrant Name	IGEN NETWORKS CORP
Entity Central Index Key	1,393,540
Document Type	10-K/A
Document Period End Date	Dec. 31, 2017
Amendment Description	We are filing this Amendment No. 1 on Form 10-K/A (the “ Amendment Form 10-K Original Filing Date 101.INS XBRL Instance Document 101.SCG XBRL Taxonomy Schema 101.CAL XBRL Taxonomy Calculation LinkBase 101.DEF XBRL Taxonomy Definition Linkbase 101.LAB XBRL Taxonomy Label Linkbase 101.PRE XBRL Taxonomy Presentation Linkbase No other changes have been made to the Form 10-K. This Amendment speaks as of the Original Filing Date and does not reflect events that may have occurred subsequent to the Original Filing Date, and does not modify or update in any way the disclosures made in the Form 10-K. As set forth in Item 15 of Part IV, the XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
Amendment Flag	true
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer	No
Is Entity a Voluntary Filer	No
Is Entity's Reporting Status Current	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 3,300,180
Entity Common Stock, Shares Outstanding		48,628,185
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,017

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Current Assets
Cash	$ 28,638	$ 40,023
Accounts and other receivables	54,121	162,429
Inventory	2,222	17,226
Prepaid expenses and deposits	22,213	18,811
Restricted cash	25,000	15,000
Total Current Assets	132,194	253,489
Equipment	2,853	7,385
Goodwill	505,508	505,508
Total Assets	640,555	766,382
Current Liabilities
Accounts payable and accrued liabilities	858,908	742,876
Current portion of deferred revenue	633,766	652,486
Notes payable	14,578	79,998
Convertible debentures, net of unamortized discount of $153,194 and $0, respectively	113,056
Derivative liabilities	227,163	27,930
Total Current Liabilities	1,847,471	1,503,290
Deferred revenue	183,576	73,985
Total Liabilities	2,031,047	1,577,275
Stockholders' Deficit
Common stock: Authorized - 375,000,000 shares with $0.001 par value Issued and outstanding - 39,214,517 and 32,389,585 shares, respectively	39,215	32,390
Share subscriptions received		25,000
Additional paid-in capital	8,854,491	8,109,286
Deferred compensation		(19,592)
Accumulated other comprehensive loss	(60,910)	(32,349)
Deficit	(10,223,288)	(8,925,628)
Total Stockholders' Deficit	(1,390,492)	(810,893)
Total Liabilities and Stockholders' Deficit	$ 640,555	$ 766,382

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Current Liabilities
Convertible debenture, net of unamortized discount	$ 153,194
Stockholders' Deficit
Common shares, shares authorized	375,000,000	375,000,000
Common shares, par value	$ 0.001	$ 0.001
Common shares, shares issued	39,214,517	32,389,585
Common shares, shares outstanding	39,214,517	32,389,585

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Revenues:
Sales, hardware and accessories	$ 971,715	$ 906,235
Sales, services	375,344	236,882
Total Revenue	1,347,059	1,143,117
Cost of goods sold	863,827	748,378
Gross Profit	483,232	394,739
Expenses:
Selling, general and administrative expenses	649,704	407,394
Payroll and related	589,798	388,625
Management and consulting fees	370,223	401,459
Total Expenses	1,609,725	1,197,478
Loss Before Other Income (Expense)	(1,126,493)	(802,739)
Other Income (Expense):
Accretion of discounts on convertible debentures	(125,231)	(34,064)
Change in fair value of derivative liabilities	27,482	10,317
Gain (loss) on settlement of debt	39,210	(1,500)
Interest expense	(32,628)	(8,772)
Total Other Income (Expense), net	(91,167)	(34,019)
Net Loss before Provision for Income Taxes	(1,217,660)	(836,758)
Provision for Income Taxes	(80,000)
Net Loss	(1,297,660)	(836,758)
Other Comprehensive Income (Loss):
Foreign currency translation loss	(28,561)	(20,478)
Comprehensive Loss	$ (1,326,221)	$ (857,236)
Basic and diluted loss per common share	$ (0.04)	$ (0.03)
Weighted Average Number of Common Shares Outstanding	35,454,849	31,120,930

Consolidated Statements of Stoc

Consolidated Statements of Stockholders Deficit - USD ($)	Common Stock	Share subscriptions Received	Additional Paid-In Capital	Deferred Compensation	Accumulated Other Comprehensive Loss	Deficit (Restated)	Total
Beginning Balance, Shares at Dec. 31, 2015	28,215,349
Beginning Balance, Amount at Dec. 31, 2015	$ 28,215	$ 25,000	$ 7,586,514	$ (54,570)	$ (11,871)	$ (7,675,552)	$ (102,264)
Stock-based compensation			52,702				52,702
Shares issued for cash, Shares	3,076,510
Shares issued for cash, Amount	$ 3,077		322,665				$ 325,742
Shares issued for services, Shares	479,290						479,290
Shares issued for services, Amount	$ 479		60,001				$ 60,480
Shares issued for exercise of options, Shares	55,556
Shares issued for exercise of options, Amount	$ 56		4,944				5,000
Share issued for debt settlement, Shares	50,000
Share issued for debt settlement, Amount	$ 50		7,450				7,500
Shares issued for debenture conversion, Shares	512,880
Shares issued for debenture conversion, Amount	$ 513		78,552				79,065
Shares issuance cost			(3,542)				(3,542)
Deferred compensation charged to operations				34,978			34,978
Foreign currency translation loss					(20,478)		(20,478)
Adjustment to accumulated deficit (see Note 18)						(413,318)	(413,318)
Net loss						(836,758)	(836,758)
Ending Balance, Shares at Dec. 31, 2016	32,389,585
Ending Balance, Amount at Dec. 31, 2016	$ 32,390	25,000	8,109,286	(19,592)	(32,349)	(8,925,628)	(810,893)
Stock-based compensation			167,772				167,772
Shares issued for cash and share subscriptions, Shares	5,672,852
Shares issued for cash and share subscriptions, Amount	$ 5,673	(25,000)	469,327				450,000
Shares issued for services, Shares	527,080
Shares issued for services, Amount	$ 527		46,231				46,758
Shares issued for debenture conversion, Shares	625,000
Shares issued for debenture conversion, Amount	$ 625		61,875				62,500
Deferred compensation charged to operations				19,592			19,592
Foreign currency translation loss					(28,561)		(28,561)
Net loss						(1,297,660)	(1,297,660)
Ending Balance, Shares at Dec. 31, 2017	39,214,517
Ending Balance, Amount at Dec. 31, 2017	$ 39,215		$ 8,854,491		$ (60,910)	$ (10,223,288)	$ (1,390,492)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash Flows from Operating Activities
Net loss	$ (1,297,660)	$ (836,758)
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion of discounts on convertible debentures	125,231	34,064
Bad debts	1,996	2,123
Change in fair value of derivative liabilities	(27,482)	(10,317)
Depreciation	4,360	10,279
Loss (gain) on settlement of debt	(39,210)	1,500
Shares issued for services	66,350	95,458
Stock-based compensation	167,772	52,702
Changes in operating assets and liabilities:
Accounts and other receivables	106,312	(113,709)
Inventory	15,004	12,417
Prepaid expenses and deposits	(3,402)	(11,913)
Restricted cash	(10,000)	(15,000)
Accounts payable and accrued liabilities	116,032	217,448
Deferred revenue	90,871	256,353
Net Cash Used in Operating Activities	(683,826)	(305,353)
Cash Flows from Financing Activities
Proceeds from notes payable	13,000
Repayment of notes payable	(80,678)	(45,369)
Proceeds from convertible debentures	316,250	54,087
Proceeds from issuance of common stock	450,000	325,742
Share issuance costs		(3,542)
Net Cash Provided by Financing Activities	698,572	330,918
Effect of Foreign Exchange Rate Changes on Cash	(26,131)	(19,132)
Change in Cash	(11,385)	6,433
Cash, Beginning of Year	40,023	33,590
Cash, End of Year	28,638	40,023
Supplemental Disclosures:
Interest paid
Income taxes paid
Non-cash Investing and Financing Activities:
Conversion option derivative liabilities recorded as debt discounts	278,425
Shares issued for subscription receivable	25,000
Shares issued for debt settlement		7,500
Shares issued for debenture conversion	62,500	79,065
Shares issued for options exercise included in accounts payable		$ 5,000

Organization and Description of

Organization and Description of Business	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
1. Organization and Description of Business	IGEN Networks Corp, (“IGEN”, or the “Company”) was incorporated in the State of Nevada on November 14, 2006. IGEN has three lines of businesses: (i) investing in and managing private high-tech companies that offer products and services in the domains of wireless broadband and machine-to-machine communications and applications; (ii) negotiating distribution agreements with relevant organizations and selling their products and services through the distribution channels of IGEN; and (iii) providing lot inventory management, asset tracking, and stolen vehicle recovery solutions to the automotive dealership industry and its customers through its wholly-owned subsidiary, Nimbo, LLC (“Nimbo”). Going Concern The consolidated financial statements as of and for the year ended December 31, 2017 have been prepared assuming that the Company will continue as a going concern. The Company has experienced recurring losses from operations, has negative operating cash flows during the years ended December 31, 2017 and 2016, has a working capital deficit of $1,715,277 and an accumulated deficit of $10,223,288 as of December 31, 2017, and is dependent on its ability to raise capital from stockholders or other sources to sustain operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Ultimately, the Company plans to achieve profitable operations through the increase in revenue base and successfully grow its operations organically or through acquisitions. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
2. Summary of Significant Accounting Policies	Basic of Presentation and Consolidation These consolidated financial statements and related notes include the records of the Company and the Company’s wholly-owned subsidiaries, Nimbo, which is formed in the USA, and IGEN Business Solutions, Inc. (“IBS”), which was incorporated in Canada (see below). All intercompany transactions and balances have been eliminated. These consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), are expressed in U.S. dollars, and, in management’s opinion, have been properly prepared within reasonable limits of materiality and within the framework of the significant accounting policies summarized below. Use of Estimates The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for doubtful accounts, valuation of inventory, the useful life and recoverability of equipment, impairment of goodwill, valuation of notes payable and convertible debentures, fair value of derivative liabilities, fair value of stock-based compensation, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of three months or less at the time of acquisition to be cash equivalents. Accounts Receivable Accounts receivable are recognized and carried at the original invoice amount less an allowance for expected uncollectible amounts. Inherent in the assessment of the allowance for doubtful accounts are certain judgments and estimates including, among others, the customer’s willingness or ability to pay, the Company’s compliance with customer invoicing requirements, the effect of general economic conditions and the ongoing relationship with the customer. Accounts with outstanding balances longer than the payment terms are considered past due. We do not charge interest on past due balances. The Company writes off trade receivables when all reasonable collection efforts have been exhausted. Bad debt expense is reflected as a component of general and administrative expenses in the consolidated statements of operations. Inventory Inventory consists of vehicle tracking and recovery devices and is comprised entirely of finished goods that can be resold. Inventory is stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out (FIFO) basis. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and selling costs. There was no provision for inventory recorded during the years ended December 31, 2017 and 2016. Equipment Office equipment, computer equipment, and software are recorded at cost. Amortization is provided annually at rates and methods over their estimated useful lives. Management reviews the estimates of useful lives of the assets every year and adjusts them on prospective basis, if needed. All equipment was fully depreciated as of December 31, 2017. For purposes of computing depreciation, the method of depreciating equipment is as follows: Computer equipment 55% declining balance Office equipment 20% declining balance Software 3 years straight-line Goodwill Goodwill represents the excess of the acquisition price over the fair value of identifiable net assets acquired. Goodwill is allocated at the date of the business combination. Goodwill is not amortized, but is tested for impairment annually, during the fourth quarter, or more frequently if events or changes in circumstances indicate the asset may be impaired. These events and circumstances may include a significant change in legal factors or in the business climate, a significant decline in the Company’s share price, an adverse action of assessment by a regulator, unanticipated competition, a loss of key personnel, significant disposal activity and the testing of recoverability for a significant asset group. The impairment testing is carried out in two steps. In the first step, the carrying amount of the reporting unit including goodwill is compared with its fair value. When the carrying amount of a reporting unit exceeds its fair value, goodwill of the reporting unit is considered to be impaired and the second step is necessary. If the total of the expected undiscounted future cash flows is less than the carrying amount of the goodwill, a loss is recognized for the excess of the carrying amount over the fair value of the goodwill. Establishing an implied fair value of goodwill requires the Company to make estimates for key inputs into complex valuation models and to apply significant judgment in the selection of estimates, assumptions and methodologies required to complete the analysis. Areas of judgment include, but are not limited to, development of multi-year business cash flow forecasts, the selection of discount rates, and the identification and valuation of unrecorded assets. Impairment of Long-lived Assets The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in the circumstances indicate that the carrying value may not be recoverable. If the total of the estimated undiscounted future cash flows is less than the carrying value of the asset, an impairment loss is recognized for the excess of the carrying value over the fair value of the asset during the year the impairment occurs. Subsequent expenditure relating to an item of office equipment is capitalized when it is probable that future economic benefits from the use of the assets will be increased. Financial Instruments In accordance with Financial Accounting Standard Board (“FASB”) Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” the Company is to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The fair values of cash, accounts and other receivables, restricted cash, and accounts payable and accrued liabilities, approximate their carrying values due to the immediate or short-term maturity of these financial instruments. Foreign currency transactions are primarily undertaken in Canadian dollars. The fair value of cash is determined based on “Level 1” inputs and the fair value of derivative liabilities is determined based on “Level 3” inputs. The recorded values of notes payable, approximate their current fair values because of their nature and respective maturity dates or durations. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility to these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. Financial instruments that potentially subject the Company to concentrations of credit risk consists of cash. The Company places its cash in what it believes to be credit-worthy financial institutions. Revenue Recognition and Deferred Revenue The Company derives revenue from the sale of devices and services provided in relation to vehicle tracking and recovery. In accordance with ASC 605, “Revenue Recognition”, revenue is recognized when all the following conditions are met: · There is clear evidence that an arrangement exists; · Services are provided or products are delivered to customers; · Amounts are fixed or can be determined; · The ability to collect is reasonably assured; · There is no significant obligation for future performance; and · The amount of future returns can be reasonably estimated. Management assesses the business environment, customers’ financial condition, historical collection experience, accounts receivable aging, and customer disputes to determine whether collectability is reasonably assured. If collectability is not considered reasonably assured at the time of sale, the Company does not recognize revenue until collection occurs. The Company has determined that the sale of our vehicle tracking device and related service is considered one unit of accounting and the revenue related to the sale is deferred and recognized over the service term, typically one year. Revenue relating to the sale of service renewal fees on its vehicle tracking and recovery services is recognized over the life of the contract. The service renewal fees are offered in terms ranging from 12 to 36 months and are generally payable in full upon renewal. Any revenue that has been deferred and is expected to be recognized beyond one year is classified as long-term deferred revenue. Financing Costs and Debt Discount Financing costs and debt discounts are recorded net of notes payable and convertible debentures in the consolidated balances sheet. Amortization of financing costs and the debt discounts is calculated using the effective interest method over the term of the debt and is recorded as interest expense in the consolidated statement of operations. Income Taxes Deferred income taxes are provided on the asset and liability method whereby deferred income tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred income tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Foreign Currency Translation The Company’s reporting currency is the U.S. dollar. The consolidated financial statements of the Company are translated to U.S. dollars in accordance with ASC 830, “Foreign Currency Translation Matters”. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets, liabilities and items recorded in income arising from transactions denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the determination of income. Assets and liabilities of the Company’s Canadian subsidiary are translated into U.S. dollars at the year-end exchange rates, and revenue and expenses are translated at the average exchange rates during the period. Exchange differences arising on translation are disclosed as a separate component of stockholders’ deficit. Stock-based Compensation The estimated fair values of employee stock option grants are determined as of the date of grant using the Black-Scholes option pricing model. This method incorporates the fair value of our common stock at the date of each grant and various assumptions such as the risk-free interest rate, expected volatility based on the historic volatility of publicly-traded peer companies, expected dividend yield, and expected term of the options. The estimated fair values of restricted stock awards are determined based on the fair value of our common stock on the date of grant. The estimated fair values of stock-based awards, including the effect of estimated forfeitures, are expensed over the requisite service period, which is generally the awards’ vesting period. We classify stock-based compensation expense in the consolidated statement of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified. Our accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the guidance of ASC 718, “Compensation – Stock Compensation”. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance is reached. For transactions in which the fair value of the equity instrument issued to non-employees is the more reliable measurement and a measurement date has not been reached, the fair value is re-measured at each vesting and reporting date using the Black-Scholes option pricing model. Compensation expense for these share-based awards is recognized over the term of the consulting agreement or until the award is approved and settled. Loss Per Share Basic earnings (loss) per share are computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted earnings per share give effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible debentures, using the if-converted method. In computing diluted earnings (loss) per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted earnings (loss) per share exclude all potentially issuable shares if their effect is anti-dilutive. Because the effect of conversion of the Company’s dilutive securities is anti-dilutive, diluted loss per share is the same as basic loss per share for the periods presented. As of December 31, 2017 and 2016, the Company has 13,021,952 and 8,055,294 potentially dilutive shares outstanding, respectively. Comprehensive Income (Loss) ASC 220, “Comprehensive Income” establishes standards for the reporting and display of comprehensive income and its components in the consolidated financial statements. For the years ended December 31, 2017, and 2016, comprehensive income (loss) consists of foreign currency translation gains and losses. Reclassifications Certain reclassifications have been made to the prior year’s consolidated financial statements to conform to the current year’s presentation. Recent Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers". This new standard will replace most of the existing revenue recognition guidance in U.S. GAAP when it becomes effective and permits the use of either the retrospective or cumulative effect transition method. The new standard, as amended, becomes effective in the first quarter of fiscal year 2018, but allows the adoption of the standard one year earlier. The Company has not yet selected a transition method and is currently assessing the impact the adoption of ASU 2014-09 will have on its consolidated financial statements and disclosures. In February 2016, the FASB issued new lease accounting guidance in ASU No. 2016-02, “Leases”. This new guidance was initiated as a joint project with the International Accounting Standards Board to simplify lease accounting and improve the quality of and comparability of financial information for users. This new guidance would eliminate the concept of off-balance sheet treatment for “operating leases” for lessees for the vast majority of lease contracts. Under ASU No. 2016-02, at inception, a lessee must classify all leases with a term of over one year as either finance or operating, with both classifications resulting in the recognition of a defined “right-of-use” asset and a lease liability on the balance sheet. However, recognition in the income statement will differ depending on the lease classification, with finance leases recognizing the amortization of the right-of-use asset separate from the interest on the lease liability and operating leases recognizing a single total lease expense. Lessor accounting under ASU No. 2016-02 would be substantially unchanged from the previous lease requirements under GAAP. ASU No. 2016-02 will take effect for public companies in fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted and for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, lessees and lessors must apply a modified retrospective transition approach. The Company is currently evaluating the new guidance and have not determined the impact this standard may have on the consolidated financial statements. In November 2016, the FASB issued ASU No. 2016-18, “Statement of Cash Flows: Classification of Restricted Cash”, which updates the guidance as to how restricted cash should be presented and classified. The updates are intended to reduce diversity in practice. The amendments are effective for fiscal years beginning after December 15, 2017, including interim periods within those annual periods, with early adoption permitted. The Company expects the implementation of this standard to have an impact on the Company’s consolidated financial statements and related disclosures as the Company had restricted cash on our consolidated balance sheet of $25,000 as of December 31, 2017, and currently do not present the amount as a cash equivalent in our consolidated statements of cash flows. In January 2017, the FASB issued ASU No. 2017-04, “Intangibles – Goodwill and Other”. ASU 2017-04 simplifies the subsequent measurement of goodwill by removing the second step of the two-step impairment test. The amendment requires an entity to perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value but the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The amendment should be applied on a prospective basis and is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company does not expect ASU 2017-04 to have a material effect on the Company’s consolidated financial position, results of operations and cash flows. The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.

Accounts and Other Receivables

Accounts and Other Receivables	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
3. Accounts and Other Receivables	December 31, 2017 December 31, 2016 Trade accounts receivable $ 55,575 $ 149,825 GST and other receivable 164 14,222 Allowance for doubtful accounts (1,618 ) (1,618 ) $ 54,121 $ 162,429

Equipment

Equipment	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
4. Equipment	December 31, 2017 December 31, 2016 Computer equipment $ 44,166 $ 52,303 Office equipment 1,603 1,603 Software 6,012 6,012 Total 51,781 59,818 Accumulated depreciation (48,928 ) (52,533 ) Total $ 2,853 $ 7,385

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
5. Goodwill	As of December 31, 2017 and 2016, the Company had goodwill of $505,508 related to the acquisition of Nimbo.

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
6. Accounts Payable and Accrued Liabilities	December 31, 2017 December 31, 2016 Trade accounts payable 623,375 $ 652,537 Accrued liabilities 49,696 39,035 Accrued interest payable 17,057 12,862 Payroll and commissions payable 84,299 32,063 Unrecognized tax position 80,000 - Taxes payable 4,481 6,379 858,908 $ 742,876

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
7. Notes Payable	(a) On September 30, 2014, the Company issued a note payable with principal of $95,000 in exchange for settlement of accounts payable of the same amount. The note payable was unsecured, bore interest at 5% per annum, and was due on demand. The note payable was accounted for at amortized cost using the effective interest rate method with the effective interest rate of 14% per annum. The Company recorded a debt discount of $16,163 to the note payable, which was amortized in full as of December 31, 2016, and a corresponding amount to additional paid-in capital at issuance. During the year ended December 31, 2016, the Company amortized $7,762 of the debt discount to interest expense. During the year ended December 31, 2016, the Company repaid $30,000 of the principal. During the year ended December 31, 2017, the Company repaid the remaining balance of $65,000 of the principal and $7,000 of accrued interest. As of December 31, 2017 and 2016, the carrying value of the note payable was $0 and $65,000, respectively, and the Company had an outstanding accrued interest balance of $0 and $10,711, respectively, which has been included in accounts payable and accrued liabilities. (b) As of December 31, 2017 and 2016, the Company had a note payable with a principal balance of $11,952 (Cdn$15,000) and $14,998 (Cdn$20,000), respectively, owed to a director, which is unsecured, bears interest at 5% per annum, and was due on October 30, 2017, and is now due on demand. As of December 31, 2017 and 2016, the Company had an outstanding accrued interest balance of $2,386 (Cdn$2,960) and $2,151 (Cdn$2,373), respectively, which has been included in accounts payable and accrued liabilities. (c) On March 23, 2017, the Company entered into a loan agreement with a third party for a principal amount of $8,695, which includes a one-time loan fee of $695, which was charged to interest expense. The note payable is unsecured, non-interest bearing, and requires minimum payments of 10% of the loan every ninety days from the start date of March 26, 2017. 25% of all funds processed through the Company’s PayPal account will be used to pay off the loan until the loan is repaid in full. As of December 31, 2017 and 2016, the balance of the note payable was $2,626 and $0, respectively.

Convertible Debentures

Convertible Debentures	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
8. Convertible Debentures	(a) On June 1, 2016, the Company issued two convertible debentures in the principal amounts of $37,577 (Cdn$50,000) and $15,031 (Cdn$20,000), respectively. Under the terms of the debentures, the amounts were unsecured, bore interest at 15% per annum, payable monthly or at term, and were due on the four month anniversary of the closing dates of June 8, 2016 (i.e. October 8, 2016). Subject to the approval of the holder of the convertible debentures, the Company may convert any or all of the principal and/or interest at any time following the four month anniversary of the issuance date of the convertible debentures into common shares of the Company at a price per share equal to a 20% discount to the fair market value of the Company’s common stock. The Company analyzed the conversion option under ASC 815, “Accounting for Derivative Instruments and Hedging Activities” (“ASC 815”), and determined that the conversion feature should be classified as a liability and recorded at fair value due to there being no explicit limit to the number of shares to be delivered upon settlement of the conversion option. In accordance with ASC 815, the Company recognized the estimated fair value of the embedded conversion feature of $26,306. On October 8, 2016, the note became convertible resulting in the Company recording a derivative liability of $26,306 with a corresponding adjustment to loss on change in fair value of derivative liabilities. On October 13, 2016, the Company issued 512,880 shares of common stock for the full conversion of $54,087 (Cdn$70,000) of these debentures and $2,941 (Cdn$3,855) of accrued interest (see Note 11). During the year ended December 31, 2016, the Company amortized $26,306 of the debt discount to accretion of discount on convertible debentures expense. (b) On March 30, 2017, the Company issued a convertible debenture to a third party in the principal amount of $50,000 which is unsecured, bears interest at 12% per annum, calculated monthly, and was due on September 30, 2017, and is now due on demand. Subject to the approval of the holder of the convertible debenture, the Company may convert any or all of the principal and/or interest at any time following the six month anniversary of the issuance date of the convertible debenture (September 30, 2017) into common shares of the Company at a price per share equal to a 20% discount to the fair market value of the Company’s common stock. The estimated fair value of the derivative liability resulted in a discount to the convertible debenture of $32,127, which was accreted over the term of the convertible debenture. During the years ended December 31, 2017 and 2016, $32,127 and $0, respectively, of amortization expense was recorded. As of December 31, 2017 and 2016, the carrying value of the convertible debenture is $50,000 and $0, respectively. (c) On May 1, 2017, the Company issued two convertible debentures for aggregate proceeds of $50,000 which were unsecured, bore interest at 12% per annum, calculated monthly, and were due on May 1, 2019. Subject to the approval of the holder of the convertible debenture, the Company may convert any or all of the principal and/or interest at any time following the six month anniversary of the issuance date of the convertible debenture (November 1, 2017) into common shares of the Company at a price per share equal to a 20% discount to the fair market value of the Company’s common stock. The estimated fair value of the derivative liabilities resulted in a discount to the convertible debentures of $45,400, which was accreted over the term of the convertible debenture. On November 1, 2017, the Company issued 625,000 shares of common stock for the full conversion of these debentures. The discount was amortized in full as a result of the conversion. During the years ended December 31, 2017 and 2016, $45,400 and $0, respectively, of accretion expense was recorded. (d) On August 7, 2017, the Company issued a convertible debenture to a third party in the principal amount of $161,250 with an original issuance discount of $11,250 and incurred $3,500 of financing costs to a third party, which is unsecured, bears interest at 5% per annum, and is due on August 7, 2018. The holder may convert any or all of the principal and/or interest at any time following the six month anniversary of the issuance date of the convertible debenture (February 7, 2018) into common shares of the Company at a price per share equal to 75% multiplied by the closing price of the Company’s common stock preceding the trading day that the Company receives a notice of conversion. The estimated fair value of the derivative liabilities of $153,827 resulted in a discount to the convertible debenture, which will be amortized over the term of the convertible debenture. During the years ended December 31, 2017 and 2016, $47,632 and $0, respectively, of amortization expense was recorded. As of December 31, 2017 and 2016, the carrying value of the convertible debenture is $55,055 and $0, respectively. (e) On December 18, 2017, the Company issued a convertible debenture to a third party in the principal amount of $55,000 with an original issuance discount of $5,000 and incurred $1,500 of financing costs to a third party, which is unsecured, bears interest at 2% per annum, and is due on June 18, 2018. The holder may convert any or all of the principal and/or interest at any time following the six month anniversary of the issuance date of the convertible debenture (June 18, 2018) into common shares of the Company at a price per share equal to 75% multiplied by the closing price of the Company’s common stock preceding the trading day that the Company receives a notice of conversion. The estimated fair value of the derivative liabilities of $47,071 resulted in a discount to the convertible debenture, which will be amortized over the term of the convertible debenture. During the year ended December 31, 2017 and 2016, $72 and $0, respectively, of amortization expense was recorded. As of December 31, 2017 and 2016, the carrying value of the convertible debenture is $8,001 and $0, respectively.

Derivative Liabilities

Derivative Liabilities	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
9. Derivative Liabilities	During the year ended December 31, 2016, the Company issued share purchase warrants as part of private placements with exercise prices denominated in Canadian dollars, which differs from the Company’s functional currency of U.S. dollars (Note 12) and cannot be considered to be indexed to the Company’s own stock. The Company records the fair value of its share purchase warrants with a Cdn$ exercise price in accordance with ASC 815. The fair value of the derivative liabilities is revalued on each balance sheet date with corresponding gains and losses recorded in the consolidated statements of operations. As of December 31, 2017 and 2016, the Company had a derivative liability of $7,642 and $27,930, respectively, relating to the share purchase warrants. The Company uses a multi-nominal lattice model to fair value the derivative liabilities. The following inputs and assumptions were used to value the share purchase warrants denominated in Canadian dollars during the years ended December 31, 2017 and 2016, assuming no expected dividends: 2017 2016 Expected volatility 195% - 196 % 148% - 233 % Risk free interest rate 1.06% - 1.39 % 0.44% - 0.85 % Expected life (in years) 0.25 – 0.50 0.40 - 1.20 During the years ended December 31, 2017 and 2016, the Company issued convertible debentures with variable exercise prices based on market rates (see Note 8). The Company records the fair value of the conversion features with variable exercise prices based on future market rates in accordance with ASC 815. The fair value of the derivative liabilities is revalued on each balance sheet date with corresponding gains and losses recorded in the consolidated statements of operations. The Company uses a multi-nominal lattice model to fair value the derivative liabilities. The following inputs and assumptions were used to value the conversion features outstanding during the years ended December 31, 2017 and 2016, assuming no expected dividends: 2017 2016 Expected volatility 187% - 225 % 175 - 233 % Risk free interest rate 1.22% - 1.62 % 0.26 % Expected life (in years) 0.16 – 1.50 0.10 The following table provides a reconciliation of the beginning and ending balances for our liabilities measured at fair value using Level 3 inputs for the years ended December 31: 2017 2016 Balance at January 1, $ 27,930 $ 33,982 Issuance of embedded conversion derivative liabilities 278,425 26,306 Extinguishment due to conversion of convertible debentures (51,710 ) (22,041 ) Change in fair value (27,482 ) (10,317 ) Total $ 227,163 $ 27,930

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
10. Related Party Transactions	(a) During the years ended December 31, 2017 and 2016, the Company incurred $227,080 and $250,200, respectively, in management and consulting fees to two officers and a Company controlled by a director. (b) As of December 31, 2017 and 2016, the Company owed $133,535 and $132,053, respectively, to directors and officers and a company controlled by a director, which is included in accounts payable and accrued liabilities. The amounts owed are unsecured, non-interest bearing, and due on demand.

Stockholders Deficit

Stockholders Deficit	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
11. Stockholders Deficit	Preferred Stock On January 17, 2018, a new class of preferred stock consisting of 10,000,000 shares, with rights and privileges to be determined by the Board of Directors at a later date, was approved by the stockholders of the Company. Common Stock 2017 (a) On March 2, 2017, the Company issued 2,222,222 units at $0.09 per unit for proceeds of $200,000. Each unit consisted of one share of common stock and one share purchase warrant exercisable until March 2, 2019. The share purchase warrant is exercisable at $0.18 per share for the first year and $0.23 per share thereafter. (b) On March 2, 2017, the Company issued 56,000 shares of common stock with a fair value of $5,640 based on the closing price of the Company’s common stock for consulting services rendered by a company controlled by the Vice President of Finance of the Company. (c) On April 20, 2017, the Company issued 49,020 shares of common stock with a fair value of $5,392 based on the closing price of the Company’s common stock for consulting services rendered. (d) On June 23, 2017, the Company issued 147,059 units at $0.17 per unit for proceeds of $25,000 which was received as at December 31, 2016. Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.35 per share for a period of two years from their date of issuance. (e) On July 1, 2017, the Company issued 49,020 shares of common stock with a fair value of $4,902 based on the closing price of the Company’s common stock for consulting services rendered. (f) On August 29, 2017, the Company issued 1,875,000 shares of common stock at $0.08 per share for proceeds of $150,000. (g) On September 7, 2017, the Company issued 49,020 shares of common stock with a fair value of $3,922 based on the closing price of the Company’s common stock for consulting services rendered. (h) On October 1, 2017, the Company issued 75,000 shares of common stock with a fair value of $6,000 based on the closing price of the Company’s common stock for consulting services rendered. (i) On October 5, 2017, the Company issued 50,000 shares of common stock with a fair value of $4,000 based on the closing price of the Company’s common stock for consulting services rendered. (j) On October 17, 2017, the Company issued 150,000 shares of common stock to an employee with a fair value of $12,000 based on the closing price of the Company’s common stock for a bonus. (k) On November 1, 2017, the Company issued 625,000 shares of common stock with a fair value of $62,500 based on the closing price of the Company’s common stock for the conversion of two convertible notes payable with an aggregate value of $50,000 and derivative liabilities of $51,710. The Company recorded a gain on settlement of debt of $39,210 in connection with this debt settlement. (l) On November 6, 2017, the Company issued 1,428,571 shares of common stock at $0.07 per share for proceeds of $100,000. (m) On December 31, 2017, the Company issued 49,020 shares of common stock with a fair value of $4,902 based on the closing price of the Company’s common stock for consulting services rendered. (n) During the year ended December 31, 2015, the Company issued 498,801 shares of common stock with a fair value of $107,944 based on the closing price of the Company’s common stock for services. Of this amount, $70,300 relates to services to be rendered, which was recorded as deferred compensation. During the year ended December 31, 2017, the Company expensed $19,592 (2016 - $34,978) of the deferred compensation as consulting fees, which reflects the pro-rata portion of the services provided through July 24, 2017. The services have been fully earned as of July 24, 2017. 2016 (o) On January 7, 2016, the Company issued 55,556 shares of common stock for proceeds of $5,000 pursuant to the exercise of options. (p) On March 29, 2016, the Company issued 588,240 units for proceeds of $76,029 (Cdn$100,000). Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.25 (Cdn$0.34) per share until March 29, 2018. (q) On May 4, 2016, the Company issued 250,000 units for proceeds of $22,770 (Cdn$30,000). Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.15 per share until May 4, 2018. (r) On June 9, 2016, the Company issued 312,500 units for proceeds of $39,283 (Cdn$50,000). Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.20 per share until June 9, 2017. (s) On October 12, 2016, the Company issued 357,143 units for proceeds of $37,659 (Cdn$50,000). Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.18 per share until October 12, 2017. In relation to this financing, the Company paid finder’s fees of $3,542, which was recorded as share issuance costs. (t) On October 12, 2016, the Company issued 50,000 shares of common stock with a fair value of $7,500 based on the closing price of the Company’s common stock for the settlement of debt of $6,000. There Company recorded a loss on settlement of debt of $1,500 in connection with this debt settlement. (u) On October 12, 2016, the Company issued 512,880 shares of common stock upon the conversion of two convertible debentures and accrued interest totaling $79,065. (v) On December 5, 2016, the Company issued 980,392 units for proceeds of $100,000. Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.15 per share until December 5, 2017. (w) On December 13, 2016, the Company issued 588,235 units for proceeds of $50,000. Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.12 per share until December 13, 2017. (x) During the year ended December 31, 2016, the Company issued 479,290 shares of common stock with the fair value of $60,480 based on the closing price of the Company’s common stock for consulting services rendered by external consultants.

Share Purchase Warrants

Share Purchase Warrants	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
12. Share Purchase Warrants	The following table summarizes the continuity schedule of the Company’s share purchase warrants: Number of warrants Weighted average exercise price Balance, December 31, 2015 1,125,843 $ 0.30 Issued 3,076,510 0.17 Expired (147,059 ) 0.40 Balance, December 31, 2016 4,055,294 0.20 Issued 2,419,281 0.17 Expired (2,236,662 ) 0.22 Balance, December 31, 2017 4,237,913 $ 0.19 As of December 31, 2017, the following share purchase warrants were outstanding: Number of warrants outstanding Exercise price Expiration date 588,240 Cdn$0.34 March 29, 2018 250,000 $ 0.15 May 4, 2018 2,222,222 $ 0.18 March 2, 2019 147,059 $ 0.35 June 23, 2019 980,392 $ 0.15 December 2, 2021 50,000 $ 0.20 January 2, 2022 4,237,913 During the year ended December 31, 2017, the Company issued 50,000 share purchase warrants with a fair value of $2,185 as contract fees to a third party for future financing, which was recorded as stock-based compensation expense. The Company uses the Black-Scholes option pricing model to establish the fair value of share purchase warrants issued, assuming no expected dividends or forfeitures, volatility of 173%, risk-free rate of 1.14%, and an expected life of 3 years.

Stock Options

Stock Options	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
13. Stock Options	The following table summarizes the continuity schedule of the Company’s stock options: Number of options Weighted average exercise price Aggregate intrinsic value Balance, December 31, 2015 4,080,556 $ 0.12 Granted 675,000 0.13 Exercised (55,556 ) 0.09 Cancelled / forfeited (700,000 ) 0.18 Balance, December 31, 2016 4,000,000 0.16 Granted 1,800,000 0.12 Cancelled / forfeited (625,000 ) 0.14 Balance, December 31, 2017 5,175,000 $ 0.15 $ 11,350 Outstanding Exercisable Range of exercise prices Number of shares Weighted average remaining contractual life (years) Weighted average exercise price Number of shares Weighted average exercise price $ 0.07 75,000 0.3 $ 0.07 75,000 $ 0.07 $ 0.08 250,000 4.8 0.08 250,000 0.08 $ 0.09 910,000 0.3 0.09 910,000 0.09 $ 0.13 1,425,000 4.4 0.13 1,100,000 0.13 $ 0.16 225,000 3.1 0.16 112,500 0.16 $ 0.19 2,270,000 2.7 0.19 2,270,000 0.19 Cdn$0.25 20,000 2.7 Cdn$0.25 20,000 Cdn$0.25 5,175,000 2.8 $ 0.15 4,737,500 $ 0.15 2017 On May 11, 2017, the Company granted 1,550,000 stock options to officers, directors, employees, and consultants of the Company, which are exercisable at $0.13 per share and expire on May 11, 2022. Of this amount, 1,150,000 stock options vested on the date of grant, 50,000 stock options vested on October 21, 2017, 50,000 stock options vested on November 11, 2017, and the remaining 300,000 stock options are scheduled to vest on May 11, 2018. During the year ended December 31, 2017, one employee and one consultant were terminated and a total of 125,000 options were cancelled. On October 6, 2017, the Company granted 250,000 stock options to a consultant, which are exercisable at $0.08 per share, expire on October 6, 2022 and vested immediately. 2016 On April 18, 2016, the Company granted 200,000 stock options to an employee with an exercise price of $0.14 per share with an expiry date of April 18, 2020. The options vest 25% on July 18, 2016, 25% on October 18, 2016, and 50% on April 18, 2017. On July 21, 2016, the Company granted 150,000 stock options to an employee with an exercise price of $0.16 per share with an expiry date of November 1, 2020. The options vest 50% on November 1, 2016 and 50% on November 1, 2017. On July 21, 2016, the Company granted 25,000 stock options to an employee with an exercise price of $0.16 per share with an expiry date of July 21, 2021. The options vest 50% on July 21, 2017 and 50% on July 21, 2018. On October 3, 2016, the Company granted 50,000 stock options to two consultants with an exercise price of $0.16 per share with an expiry date of October 3, 2021. The options vest 50% on August 9, 2017 and 50% on August 9, 2018. On October 3, 2016, the Company granted 250,000 stock options to a consultant with an exercise price of $0.10 per share with an expiry date of October 3, 2021. The options vest 20% immediately and 200,000 quarterly thereafter. The fair values of stock options granted are amortized over the vesting period where applicable. During the years ended December 31, 2017 and 2016, the Company recorded $165,587 and $52,702, respectively, in stock-based compensation in connection with the vesting of options granted. The Company uses the Black-Scholes option pricing model to establish the fair value of options granted assuming no expected dividends or forfeitures and the following weighted average assumptions: 2017 2016 Expected volatility 136 % 124 % Risk free interest rate 1.80 % 1.16 % Expected life (in years) 4.8 4.0

Segments

Segments	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
14. Segments	The Company has one reportable segment: vehicle tracking and recovery solutions. The Company allocates resources to and assesses the performance of each reportable segment using information about its revenue and operating income (loss). The Company does not evaluate operating segments using discrete asset information. Segmentation by geographical location is not presented as all revenues are earned in U.S. Total assets by segment are not presented as that information is not used to allocate resources or assess performance at the segment level and is not reviewed by the Chief Operating Decision Maker of the Company.

Concentration Risk

Concentration Risk	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
15. Concentration Risk	The Company extends credit to customers on an unsecured basis in the normal course of business. The Company’s policy is to perform an analysis of the recoverability of its receivables at the end of each reporting period and to establish allowances where appropriate. The Company analyzes historical bad debts and contract losses, customer concentrations, and customer credit-worthiness when evaluating the adequacy of the allowances. During the years ended December 31, 2017 and 2016, the Company had two customers which accounted for 74% and 66%, respectively, of total invoiced amounts, which are recorded as deferred revenues and amortized over the related service period to revenues. As of December 31, 2017 and 2016, the Company had three and two customers, respectively, which accounted for 100% and 90%, respectively, of the gross accounts receivable balance.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
16. Income Taxes	The Company’s income tax provision consists of the following: 2017 2016 Current: Federal $ 80,000 $ - State - - Foreign - - Total Current 80,000 - Deferred: Federal - - State - - Foreign - - Total Deferred - - Provision for income taxes $ 80,000 $ - A reconciliation of income taxes computed by applying the statutory U.S. income tax rate to the Company's loss before income taxes to the income tax provision is as follows: 2017 2016 Computed tax benefit at federal statutory rate $ (441,204 ) $ (334,703 ) Permanent items (4,016 ) 78,459 Stock-based compensation 21,635 - Incentive stock options 57,042 - Conversion feature derivative liability 16,785 - Impact of tax law change in rate 720,057 - Change in tax rates and true up - (262,355 ) Uncertain tax positions 80,000 - Impact of difference related to foreign earnings - 33,247 Valuation allowance (370,299 ) 485,352 Provision for income taxes $ 80,000 $ - Deferred tax assets and liabilities reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets are as follows: 2017 2016 Deferred Tax Assets: Net operating loss carryforwards $ 1,798,000 $ 2,236,248 Stock-based compensation 1,000 - Accounts receivable and other timing differences 121,000 - Basis difference in assets and debt 61,000 - Equipment - 19,367 Share issuance costs - 976 Total Deferred Tax Asset 1,981,000 2,256,591 Valuation allowance (1,981,000 ) (2,256,591 ) Net Deferred Tax Asset $ - $ - Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net deferred tax assets for the U.S. federal, state, and Canada have been fully offset by a valuation allowance. As of December 31, 2017 and 2016, the Company had net operating loss carryforwards for federal and state income tax purposes of $5,299,849 and $5,954,978, respectively, which expire beginning in the year 2029. As of December 31, 2017, the Company had net operating loss carryforwards for foreign income tax purposes of $1,046,761 which expire beginning in the year 2032. The Company is required to file US federal, California, and Canadian tax returns. Due to the Company's loss position the statute remains open for any losses carried over into the current year which means all years from 2006 remain open to examination. The Company has adopted FASB ASC 740, “Income Taxes” to account for income taxes. ASC 740 clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statement. This standard prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in the tax return. ASC 740 also provides guidance on derecognition of tax benefits, classification on the balance sheet, interest and penalties, accounting in interim periods, disclosure and transaction. In accordance with ASC 740-10-50, the Company is classifying interest and penalties as a component of tax expense. The Company has a reserve related to unrecognized tax positions of $80,000 as of December 31, 2017, which is presented as part of accounts payable and accrued liabilities. These unrecognized tax positions, if recognized, would affect the effective tax rate. A reconciliation of the change in the unrecognized tax positions for the year ended December 31, 2017 is as follows: Federal and State Balance at December 31, 2016 $ - Additions for tax positions related to current year 10,000 Additions for tax positions related to prior years 70,000 Balance at December 31, 2017 80,000 On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (the "Act"). The Act amends the Internal Revenue Code to reduce tax rates and modify policies, credits, and deductions for individuals and businesses. For businesses, the Act reduces the corporate tax rate from a maximum of 35% to a flat 21% rate. The rate reduction is effective on January 1, 2018. As a result of the rate reduction, the Company has reduced the deferred tax asset balance as of December 31, 2017 by $720,057. Due to the Company's full valuation allowance position, there was no net impact on the Company's income tax provision at December 31, 2017 as the reduction in the deferred tax asset balance was fully offset by a corresponding decrease in the valuation allowance. In conjunction with the Tax Act, the SEC staff issued Staff Accounting Bulletin No. 118 to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the Tax Act. The Company has recognized the provisional tax impacts related to the revaluation of deferred tax assets and liabilities at December 31, 2017. There was no net impact on the Company's consolidated financial statements for the year ended December 31, 2017 as the corresponding adjustment was made to the valuation allowance. The ultimate impact may differ from these provisional amounts, possibly materially, due to, among other things, additional analysis, changes in interpretations and assumptions the Company has made, additional regulatory guidance that may be issued, and actions the Company may take as a result of the Tax Act.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
17. Commitments and Contingencies	Operating Lease In April 2017, we entered into non-cancelable operating lease amendment for 2,119 square feet of office space through April 2019. Rent expense for the years ended December 31, 2017 and 2016 was approximately $47,000 and $45,000, respectively. As of December 31, 2017, we are obligated to make minimum lease payments under our operating lease as follows: Year ending December 31, Lease Payments 2018 $ 38,900 2019 13,100 Total $ 52,000 Investor Relations Agreement In September 2017, we entered into an investor relations agreement with a consultant commencing in October 2017 for a period of one year. Per the terms of the agreement, the Company is to provide to the consultant the following: cash fee of $2,500 per month; shares of common stock valued at $7,500 (75,000 shares) for the first three months of service; shares of common stock valued at $22,500 (225,000 shares) for months four through twelve. Indemnities and Guarantees We have made certain indemnities and guarantees, under which we may be required to make payments to a guaranteed or indemnified party, in relation to certain transactions. We indemnify our officers and directors to the maximum extent permitted under the laws of the State of Nevada. The duration of these indemnities and guarantees varies and, in certain cases, is indefinite. These indemnities and guarantees do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these indemnities and guarantees in the accompanying consolidated balance sheets. Legal Matters In the ordinary course of business, we may face various claims brought by third parties and may, from time to time, make claims or take legal actions to assert our rights, including intellectual property disputes, contractual disputes and other commercial disputes. Any of these claims could subject us to litigation. Management believes there are currently no claims that are likely to have a material effect on our consolidated financial position and results of operations.

Restatement

Restatement	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
18. Restatement	In connection with the audit of the Company’s consolidated financial statements for the fiscal year ended December 31, 2017, management of the Company conducted an analysis of the Company’s sales contracts related to its vehicle tracking device and service (“Sales Contracts”) and concluded they should be considered one unit of accounting and the revenue related to the sale should be deferred and recognized over the service term, typically one year. The Company determined that the original accounting for the Sales Contracts failed to appropriately record the sales proceeds as deferred revenue upon collection and recognized over the service term. As a result of this analysis, the Company concluded that it was necessary to restate its previously filed consolidated financial statements for the year ended December 31, 2016 in the consolidated financial statements for the year ended December 31, 2017. The need to restate the Company’s consolidated financial statements is primarily due to the incorrect application of U.S. GAAP. The restatement is required to properly reflect the Company’s consolidated financial position as of December 31, 2016. The effect on the consolidated balance sheet for the year ended December 31, 2016 is due to the recording of the Sales Contracts in accordance with U.S. GAAP. Accordingly, the consolidated balance sheet and statement of stockholders’ equity (deficit) for the year ended December 31, 2016 has been retroactively adjusted by $413,318 with no impact on net loss.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
19. Subsequent Events	On January 1, 2018, the Company issued 274,020 shares of common stock to consultants for services provided. On January 22, 2018, the Company issued 2,777,778 shares of common stock at $0.072 per share for proceeds of $200,000. On January 29, 2018, the Company issued 5,000,000 shares of common stock at $0.08 per share for proceeds of $400,000. On February 28, 2018, the Company issued 806,916 shares of common stock for the conversion of $50,000 in principal and $6,000 in accrued interest of a convertible debenture. Refer to Note 8(b). On March 6, 2018, the Company formed Medallion GPS, LLC, for future business opportunities. In February and March 2018, the Company issued 554,954 shares of common stock for the conversion of $23,250 in principal of a convertible debenture. Refer to Note 8(d).

2. Summary of Significant Accou

2. Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2017
Summary Of Significant Accounting Policies Policies
Basic of Presentation and Consolidation	These consolidated financial statements and related notes include the records of the Company and the Company’s wholly-owned subsidiaries, Nimbo, which is formed in the USA, and IGEN Business Solutions, Inc. (“IBS”), which was incorporated in Canada (see below). All intercompany transactions and balances have been eliminated. These consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), are expressed in U.S. dollars, and, in management’s opinion, have been properly prepared within reasonable limits of materiality and within the framework of the significant accounting policies summarized below.
Use of Estimates	The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for doubtful accounts, valuation of inventory, the useful life and recoverability of equipment, impairment of goodwill, valuation of notes payable and convertible debentures, fair value of derivative liabilities, fair value of stock-based compensation, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
Cash and Cash Equivalents	The Company considers all highly liquid instruments purchased with an original maturity of three months or less at the time of acquisition to be cash equivalents.
Accounts Receivable	Accounts receivable are recognized and carried at the original invoice amount less an allowance for expected uncollectible amounts. Inherent in the assessment of the allowance for doubtful accounts are certain judgments and estimates including, among others, the customer’s willingness or ability to pay, the Company’s compliance with customer invoicing requirements, the effect of general economic conditions and the ongoing relationship with the customer. Accounts with outstanding balances longer than the payment terms are considered past due. We do not charge interest on past due balances. The Company writes off trade receivables when all reasonable collection efforts have been exhausted. Bad debt expense is reflected as a component of general and administrative expenses in the consolidated statements of operations.
Inventory	Inventory consists of vehicle tracking and recovery devices and is comprised entirely of finished goods that can be resold. Inventory is stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out (FIFO) basis. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and selling costs. There was no provision for inventory recorded during the years ended December 31, 2017 and 2016.
Equipment	Office equipment, computer equipment, and software are recorded at cost. Amortization is provided annually at rates and methods over their estimated useful lives. Management reviews the estimates of useful lives of the assets every year and adjusts them on prospective basis, if needed. All equipment was fully depreciated as of December 31, 2017. For purposes of computing depreciation, the method of depreciating equipment is as follows: Computer equipment 55% declining balance Office equipment 20% declining balance Software 3 years straight-line
Goodwill	Goodwill represents the excess of the acquisition price over the fair value of identifiable net assets acquired. Goodwill is allocated at the date of the business combination. Goodwill is not amortized, but is tested for impairment annually, during the fourth quarter, or more frequently if events or changes in circumstances indicate the asset may be impaired. These events and circumstances may include a significant change in legal factors or in the business climate, a significant decline in the Company’s share price, an adverse action of assessment by a regulator, unanticipated competition, a loss of key personnel, significant disposal activity and the testing of recoverability for a significant asset group. The impairment testing is carried out in two steps. In the first step, the carrying amount of the reporting unit including goodwill is compared with its fair value. When the carrying amount of a reporting unit exceeds its fair value, goodwill of the reporting unit is considered to be impaired and the second step is necessary. If the total of the expected undiscounted future cash flows is less than the carrying amount of the goodwill, a loss is recognized for the excess of the carrying amount over the fair value of the goodwill. Establishing an implied fair value of goodwill requires the Company to make estimates for key inputs into complex valuation models and to apply significant judgment in the selection of estimates, assumptions and methodologies required to complete the analysis. Areas of judgment include, but are not limited to, development of multi-year business cash flow forecasts, the selection of discount rates, and the identification and valuation of unrecorded assets.
Impairment of Long-lived Assets	The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in the circumstances indicate that the carrying value may not be recoverable. If the total of the estimated undiscounted future cash flows is less than the carrying value of the asset, an impairment loss is recognized for the excess of the carrying value over the fair value of the asset during the year the impairment occurs. Subsequent expenditure relating to an item of office equipment is capitalized when it is probable that future economic benefits from the use of the assets will be increased.
Financial Instruments	In accordance with Financial Accounting Standard Board (“FASB”) Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” the Company is to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The fair values of cash, accounts and other receivables, restricted cash, and accounts payable and accrued liabilities, approximate their carrying values due to the immediate or short-term maturity of these financial instruments. Foreign currency transactions are primarily undertaken in Canadian dollars. The fair value of cash is determined based on “Level 1” inputs and the fair value of derivative liabilities is determined based on “Level 3” inputs. The recorded values of notes payable, approximate their current fair values because of their nature and respective maturity dates or durations. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility to these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. Financial instruments that potentially subject the Company to concentrations of credit risk consists of cash. The Company places its cash in what it believes to be credit-worthy financial institutions.
Revenue Recognition and Deferred Revenue	The Company derives revenue from the sale of devices and services provided in relation to vehicle tracking and recovery. In accordance with ASC 605, “Revenue Recognition”, revenue is recognized when all the following conditions are met: · There is clear evidence that an arrangement exists; · Services are provided or products are delivered to customers; · Amounts are fixed or can be determined; · The ability to collect is reasonably assured; · There is no significant obligation for future performance; and · The amount of future returns can be reasonably estimated. Management assesses the business environment, customers’ financial condition, historical collection experience, accounts receivable aging, and customer disputes to determine whether collectability is reasonably assured. If collectability is not considered reasonably assured at the time of sale, the Company does not recognize revenue until collection occurs. The Company has determined that the sale of our vehicle tracking device and related service is considered one unit of accounting and the revenue related to the sale is deferred and recognized over the service term, typically one year. Revenue relating to the sale of service renewal fees on its vehicle tracking and recovery services is recognized over the life of the contract. The service renewal fees are offered in terms ranging from 12 to 36 months and are generally payable in full upon renewal. Any revenue that has been deferred and is expected to be recognized beyond one year is classified as long-term deferred revenue.
Financing Costs and Debt Discount	Financing costs and debt discounts are recorded net of notes payable and convertible debentures in the consolidated balances sheet. Amortization of financing costs and the debt discounts is calculated using the effective interest method over the term of the debt and is recorded as interest expense in the consolidated statement of operations.
Income Taxes	Deferred income taxes are provided on the asset and liability method whereby deferred income tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred income tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Foreign Currency Translation	The Company’s reporting currency is the U.S. dollar. The consolidated financial statements of the Company are translated to U.S. dollars in accordance with ASC 830, “Foreign Currency Translation Matters”. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets, liabilities and items recorded in income arising from transactions denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the determination of income. Assets and liabilities of the Company’s Canadian subsidiary are translated into U.S. dollars at the year-end exchange rates, and revenue and expenses are translated at the average exchange rates during the period. Exchange differences arising on translation are disclosed as a separate component of stockholders’ deficit.
Stock-based Compensation	The estimated fair values of employee stock option grants are determined as of the date of grant using the Black-Scholes option pricing model. This method incorporates the fair value of our common stock at the date of each grant and various assumptions such as the risk-free interest rate, expected volatility based on the historic volatility of publicly-traded peer companies, expected dividend yield, and expected term of the options. The estimated fair values of restricted stock awards are determined based on the fair value of our common stock on the date of grant. The estimated fair values of stock-based awards, including the effect of estimated forfeitures, are expensed over the requisite service period, which is generally the awards’ vesting period. We classify stock-based compensation expense in the consolidated statement of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified. Our accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the guidance of ASC 718, “Compensation – Stock Compensation”. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance is reached. For transactions in which the fair value of the equity instrument issued to non-employees is the more reliable measurement and a measurement date has not been reached, the fair value is re-measured at each vesting and reporting date using the Black-Scholes option pricing model. Compensation expense for these share-based awards is recognized over the term of the consulting agreement or until the award is approved and settled.
Loss Per Share	Basic earnings (loss) per share are computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted earnings per share give effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible debentures, using the if-converted method. In computing diluted earnings (loss) per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted earnings (loss) per share exclude all potentially issuable shares if their effect is anti-dilutive. Because the effect of conversion of the Company’s dilutive securities is anti-dilutive, diluted loss per share is the same as basic loss per share for the periods presented. As of December 31, 2017 and 2016, the Company has 13,021,952 and 8,055,294 potentially dilutive shares outstanding, respectively.
Comprehensive Income (Loss)	ASC 220, “Comprehensive Income” establishes standards for the reporting and display of comprehensive income and its components in the consolidated financial statements. For the years ended December 31, 2017, and 2016, comprehensive income (loss) consists of foreign currency translation gains and losses.
Reclassifications	Certain reclassifications have been made to the prior year’s consolidated financial statements to conform to the current year’s presentation.
Recent Accounting Pronouncements	In May 2014, the FASB issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers". This new standard will replace most of the existing revenue recognition guidance in U.S. GAAP when it becomes effective and permits the use of either the retrospective or cumulative effect transition method. The new standard, as amended, becomes effective in the first quarter of fiscal year 2018, but allows the adoption of the standard one year earlier. The Company has not yet selected a transition method and is currently assessing the impact the adoption of ASU 2014-09 will have on its consolidated financial statements and disclosures. In February 2016, the FASB issued new lease accounting guidance in ASU No. 2016-02, “Leases”. This new guidance was initiated as a joint project with the International Accounting Standards Board to simplify lease accounting and improve the quality of and comparability of financial information for users. This new guidance would eliminate the concept of off-balance sheet treatment for “operating leases” for lessees for the vast majority of lease contracts. Under ASU No. 2016-02, at inception, a lessee must classify all leases with a term of over one year as either finance or operating, with both classifications resulting in the recognition of a defined “right-of-use” asset and a lease liability on the balance sheet. However, recognition in the income statement will differ depending on the lease classification, with finance leases recognizing the amortization of the right-of-use asset separate from the interest on the lease liability and operating leases recognizing a single total lease expense. Lessor accounting under ASU No. 2016-02 would be substantially unchanged from the previous lease requirements under GAAP. ASU No. 2016-02 will take effect for public companies in fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted and for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, lessees and lessors must apply a modified retrospective transition approach. The Company is currently evaluating the new guidance and have not determined the impact this standard may have on the consolidated financial statements. In November 2016, the FASB issued ASU No. 2016-18, “Statement of Cash Flows: Classification of Restricted Cash”, which updates the guidance as to how restricted cash should be presented and classified. The updates are intended to reduce diversity in practice. The amendments are effective for fiscal years beginning after December 15, 2017, including interim periods within those annual periods, with early adoption permitted. The Company expects the implementation of this standard to have an impact on the Company’s consolidated financial statements and related disclosures as the Company had restricted cash on our consolidated balance sheet of $25,000 as of December 31, 2017, and currently do not present the amount as a cash equivalent in our consolidated statements of cash flows. In January 2017, the FASB issued ASU No. 2017-04, “Intangibles – Goodwill and Other”. ASU 2017-04 simplifies the subsequent measurement of goodwill by removing the second step of the two-step impairment test. The amendment requires an entity to perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value but the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The amendment should be applied on a prospective basis and is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company does not expect ASU 2017-04 to have a material effect on the Company’s consolidated financial position, results of operations and cash flows. The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.

Accounts and Other Receivables

Accounts and Other Receivables (Tables)	12 Months Ended
	Dec. 31, 2017
Accounts And Other Receivables Tables
Accounts and other receivables	December 31, 2017 December 31, 2016 Trade accounts receivable $ 55,575 $ 149,825 GST and other receivable 164 14,222 Allowance for doubtful accounts (1,618 ) (1,618 ) $ 54,121 $ 162,429

Equipment (Tables)

Equipment (Tables)	12 Months Ended
	Dec. 31, 2017
Equipment Tables
Property, Plant and Equipment	December 31, 2017 December 31, 2016 Computer equipment $ 44,166 $ 52,303 Office equipment 1,603 1,603 Software 6,012 6,012 Total 51,781 59,818 Accumulated depreciation (48,928 ) (52,533 ) Total $ 2,853 $ 7,385

Accounts Payable and Accrued 29

Accounts Payable and Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2017
Accounts Payable And Accrued Liabilities Tables
Schedule of Accounts Payable and Accrued Liabilities	December 31, 2017 December 31, 2016 Trade accounts payable 623,375 $ 652,537 Accrued liabilities 49,696 39,035 Accrued interest payable 17,057 12,862 Payroll and commissions payable 84,299 32,063 Unrecognized tax position 80,000 - Taxes payable 4,481 6,379 858,908 $ 742,876

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	12 Months Ended
	Dec. 31, 2017
Sehedule of derivative liabilities	2017 2016 Balance at January 1, $ 27,930 $ 33,982 Issuance of embedded conversion derivative liabilities 278,425 26,306 Extinguishment due to conversion of convertible debentures (51,710 ) (22,041 ) Change in fair value (27,482 ) (10,317 ) Total $ 227,163 $ 27,930
Warrant [Member]
Sehedule of derivative liabilities	2017 2016 Expected volatility 187% - 225 % 175 - 233 % Risk free interest rate 1.22% - 1.62 % 0.26 % Expected life (in years) 0.16 – 1.50 0.10
Convertible Debenture [Member]
Sehedule of derivative liabilities	2017 2016 Expected volatility 195% - 196 % 148% - 233 % Risk free interest rate 1.06% - 1.39 % 0.44% - 0.85 % Expected life (in years) 0.25 – 0.50 0.40 - 1.20

Share Purchase Warrants (Tables

Share Purchase Warrants (Tables)	12 Months Ended
	Dec. 31, 2017
Share Purchase Warrants Tables
Schedule of share purchase warrants	Number of warrants Weighted average exercise price Balance, December 31, 2015 1,125,843 $ 0.30 Issued 3,076,510 0.17 Expired (147,059 ) 0.40 Balance, December 31, 2016 4,055,294 0.20 Issued 2,419,281 0.17 Expired (2,236,662 ) 0.22 Balance, December 31, 2017 4,237,913 $ 0.19
Schedule of share purchase warrants outstanding	Number of warrants outstanding Exercise price Expiration date 588,240 Cdn$0.34 March 29, 2018 250,000 $ 0.15 May 4, 2018 2,222,222 $ 0.18 March 2, 2019 147,059 $ 0.35 June 23, 2019 980,392 $ 0.15 December 2, 2021 50,000 $ 0.20 January 2, 2022 4,237,913

Stock Options (Tables)

Stock Options (Tables)	12 Months Ended
	Dec. 31, 2017
Stock Options Tables
Schedule of Stock Options Roll Forward	Number of options Weighted average exercise price Aggregate intrinsic value Balance, December 31, 2015 4,080,556 $ 0.12 Granted 675,000 0.13 Exercised (55,556 ) 0.09 Cancelled / forfeited (700,000 ) 0.18 Balance, December 31, 2016 4,000,000 0.16 Granted 1,800,000 0.12 Cancelled / forfeited (625,000 ) 0.14 Balance, December 31, 2017 5,175,000 $ 0.15 $ 11,350
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range	Outstanding Exercisable Range of exercise prices Number of shares Weighted average remaining contractual life (years) Weighted average exercise price Number of shares Weighted average exercise price $ 0.07 75,000 0.3 $ 0.07 75,000 $ 0.07 $ 0.08 250,000 4.8 0.08 250,000 0.08 $ 0.09 910,000 0.3 0.09 910,000 0.09 $ 0.13 1,425,000 4.4 0.13 1,100,000 0.13 $ 0.16 225,000 3.1 0.16 112,500 0.16 $ 0.19 2,270,000 2.7 0.19 2,270,000 0.19 Cdn$0.25 20,000 2.7 Cdn$0.25 20,000 Cdn$0.25 5,175,000 2.8 $ 0.15 4,737,500 $ 0.15
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	2017 2016 Expected volatility 136 % 124 % Risk free interest rate 1.80 % 1.16 % Expected life (in years) 4.8 4.0

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2017
Income Taxes Tables
Schedule of income tax provision	2017 2016 Current: Federal $ 80,000 $ - State - - Foreign - - Total Current 80,000 - Deferred: Federal - - State - - Foreign - - Total Deferred - - Provision for income taxes $ 80,000 $ -
Schedule of reconciliation of income tax expense	2017 2016 Computed tax benefit at federal statutory rate $ (441,204 ) $ (334,703 ) Permanent items (4,016 ) 78,459 Stock-based compensation 21,635 - Incentive stock options 57,042 - Conversion feature derivative liability 16,785 - Impact of tax law change in rate 720,057 - Change in tax rates and true up - (262,355 ) Uncertain tax positions 80,000 - Impact of difference related to foreign earnings - 33,247 Valuation allowance (370,299 ) 485,352 Provision for income taxes $ 80,000 $ -
Schedule of deferred tax assets	2017 2016 Deferred Tax Assets: Net operating loss carryforwards $ 1,798,000 $ 2,236,248 Stock-based compensation 1,000 - Accounts receivable and other timing differences 121,000 - Basis difference in assets and debt 61,000 - Equipment - 19,367 Share issuance costs - 976 Total Deferred Tax Asset 1,981,000 2,256,591 Valuation allowance (1,981,000 ) (2,256,591 ) Net Deferred Tax Asset $ - $ -
Unrecognized tax benefits	Federal and State Balance at December 31, 2016 $ - Additions for tax positions related to current year 10,000 Additions for tax positions related to prior years 70,000 Balance at December 31, 2017 80,000

Commitments and Contingencies (

Commitments and Contingencies (Table)	12 Months Ended
	Dec. 31, 2017
Commitments And Contingencies Table
Schedule of future minimum operating lease commitments	Year ending December 31, Lease Payments 2018 $ 38,900 2019 13,100 Total $ 52,000

Nature and Continuance of Opera

Nature and Continuance of Operations (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Nature And Continuance Of Operations Details Narrative
State of country of incorporation	Nevada
Incorporation date	Nov. 14, 2006
Accumulated deficit	$ (10,223,288)	$ (8,925,628)
Working capital deficit	$ 1,715,277

Summary of Significant Accoun36

Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2017
Computer Equipment [Member]
Property, Plant and Equipment, Depreciation Methods	55% declining balance
Office Equipment [Member]
Property, Plant and Equipment, Depreciation Methods	20% declining balance
Software [Member]
Property, Plant and Equipment, Depreciation Methods	Straight-line
Property, Plant and Equipment, Useful Life	3 years

Summary of Significant Accoun37

Summary of Significant Accounting Policies (Details Narrative) - shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Summary Of Significant Accounting Policies Details Narrative
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	13,021,952	8,055,294

Accounts and Other Receivable38

Accounts and Other Receivables (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Accounts And Other Receivables Details
Trade accounts receivable	$ 55,575	$ 149,825
GST and other receivables	164	14,222
Allowance for doubtful accounts	(1,618)	(1,618)
Accounts and other receivables	$ 54,121	$ 162,429

Equipment (Details)

Equipment (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Cost	$ 51,781	$ 59,818
Accumulated Depreciation	(48,928)	(52,533)
Equipment, Net Carrying Value	2,853	7,385
Computer Equipment [Member]
Cost	44,166	52,303
Office Equipment [Member]
Cost	1,603	1,603
Software [Member]
Cost	$ 6,012	$ 6,012

Goodwill (Details Narrative)

Goodwill (Details Narrative) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Goodwill Details Narrative
Goodwill	$ 505,508	$ 505,508

Accounts Payable and Accrued 41

Accounts Payable and Accrued Liabilities (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Accounts Payable And Accrued Liabilities Details
Trade accounts payable	$ 623,375	$ 652,537
Accrued liabilities	49,696	39,035
Accrued interest payable	17,057	12,862
Payroll and commissions payable	84,299	32,063
Taxes payable	80,000
Unrecognized tax position	4,481	6,379
Accounts payable and accrued liabilities	$ 858,908	$ 742,876

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	Mar. 23, 2017	Sep. 30, 2014	Dec. 31, 2017	Dec. 31, 2016	Oct. 13, 2016
Accrued interest					$ 2,941
Note Payable [Member]
Debt Instrument face value		$ 95,000
Interest rate		5.00%
Debt instrument effective interest rate		14.00%
Debt discount		$ 16,163		$ 7,762
Repayments of convertible debt			$ 65,000	30,000
Notes payable				65,000
Accrued interest				10,711
Note Payable [Member] | Director [Member]
Debt Instrument face value			$ 11,952	14,998
Interest rate			5.00%
Accrued interest			$ 2,386	2,151
Maturity date			Oct. 30, 2017
Note Payable One [Member]
Notes payable			$ 0
Accrued interest			7,000
Loans Payable [Member]
Debt Instrument face value	$ 8,695
Notes payable			$ 2,626	$ 0
Loan fee	$ 695
Notes Payable, Other Payables [Member]
Description of debt Instrument payment terms	Minimum payments of 10% of the loan every ninety days from the start date of March 26, 2017. 25% of all funds processed through the Company's PayPal account will be used to pay off the loan until the loan is repaid in full

Convertible Debentures (Details

Convertible Debentures (Details Narrative)	Nov. 02, 2017shares	Aug. 07, 2017USD ($)	May 01, 2017USD ($)Number	Oct. 13, 2016USD ($)shares	Oct. 08, 2016USD ($)	Jun. 01, 2016USD ($)	Mar. 30, 2017USD ($)	Dec. 31, 2017USD ($)	Dec. 18, 2017USD ($)	Dec. 31, 2016USD ($)
Accretion expense								$ 125,231		$ 34,064
Financing costs related to issuance of convertible debenture										3,542
Change in fair value of derivative liabilities					$ 26,306
Conversion of debt to common stock shares | shares	625,000			512,880
Proceeds from convertible debentures				$ 54,087				316,250		54,087
Accrued interest				$ 2,941
Convertible debenture								113,056
Convertible Debenture Three [Member]
Debt Instrument face value			$ 50,000
Interest rate			12.00%
Number of convertible debentures | Number			2
Convertible debt terms of conversion feature			Subject to the approval of the holder of the convertible debenture, the Company may convert any or all of the principal and/or interest at any time following the six month anniversary of the issuance date of the convertible debenture (November 1, 2017) into common shares of the Company at a price per share equal to a 20% discount to the fair market value of the Company?s common stock.
Convertible debenture, discount			$ 45,400
Accretion expense								45,400		0
Maturity Date			May 1, 2019
Convertible Debenture Two [Member]
Debt Instrument face value							$ 50,000
Interest rate							12.00%
Convertible debt terms of conversion feature							Subject to the approval of the holder of the convertible debenture, the Company may convert any or all of the principal and/or interest at any time following the six month anniversary of the issuance date of the convertible debenture (September 30, 2017) into common shares of the Company at a price per share equal to a 20% discount to the fair market value of the Company?s common stock.
Convertible debenture, discount							$ 32,127
Accretion expense								32,127		0
Maturity Date							Sep. 30, 2017
Convertible debenture								50,000		0
Convertible Debenture [Member]
Debt Instrument face value						$ 37,577
Interest rate						15.00%
Number of convertible debentures						2
Convertible debt terms of conversion feature						Subject to the approval of the holder of the convertible debentures, the Company may convert any or all of the principal and/or interest at any time following the four month anniversary of the issuance date of the convertible debentures into common shares of the Company at a price per share equal to a 20% discount to the fair market value of the Company’s common stock.
Convertible debenture, discount										26,306
Maturity Date						Jun. 8, 2016
Convertible Debenture One [Member]
Debt Instrument face value						$ 15,031
Interest rate						15.00%
Number of convertible debentures						2
Convertible debt terms of conversion feature						Subject to the approval of the holder of the convertible debentures, the Company may convert any or all of the principal and/or interest at any time following the four month anniversary of the issuance date of the convertible debentures into common shares of the Company at a price per share equal to a 20% discount to the fair market value of the Company’s common stock.
Maturity Date						Jun. 8, 2016
Convertible Debenture Five [Member]
Debt Instrument face value									$ 55,000
Interest rate									2.00%
Convertible debt terms of conversion feature									The holder may convert any or all of the principal and/or interest at any time following the six month anniversary of the issuance date of the convertible debenture (June 18, 2018) into common shares of the Company at a price per share equal to 75% multiplied by the closing price of the Company?s common stock preceding the trading day that the Company receives a notice of conversion.
Convertible debenture, discount									$ 47,071
Accretion expense								72		0
Original issuance discount of convertible debentures									5,000
Financing costs related to issuance of convertible debenture									$ 1,500
Convertible debenture								8,001		0
Convertible Debenture Four [Member]
Debt Instrument face value		$ 161,250
Interest rate		5.00%
Convertible debt terms of conversion feature		The holder may convert any or all of the principal andor interest at any time following the six month anniversary of the issuance date of the convertible debenture (February 7, 2018) into common shares of the Company at a price per share equal to 75% multiplied by the closing price of the Companys common stock preceding the trading day that the Company receives a notice of conversion
Convertible debenture, discount		$ 153,827
Accretion expense								0		47,632
Original issuance discount of convertible debentures		11,250
Financing costs related to issuance of convertible debenture		$ 3,500
Maturity Date		Aug. 7, 2018
Convertible debenture								$ 0		$ 55,055

Derivative Liabilities (Details

Derivative Liabilities (Details)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Expected volatility	173.00%
Risk free interest rate	1.14%
Expected life (in years)	3 years
Warrant [Member] | Minimum [Member]
Expected volatility	195.00%	1.48%
Risk free interest rate	1.06%	0.44%
Expected life (in years)	3 months	4 months 24 days
Warrant [Member] | Maximum [Member]
Expected volatility	196.00%	233.00%
Risk free interest rate	1.39%	0.85%
Expected life (in years)	6 months	1 year 2 months 12 days

Derivative Liabilities (Detai45

Derivative Liabilities (Details 1)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Expected volatility	173.00%
Risk free interest rate	1.14%
Expected life (in years)	3 years
Convertible Debenture [Member]
Risk free interest rate		0.26%
Expected life (in years)		1 month 6 days
Convertible Debenture [Member] | Minimum [Member]
Expected volatility	187.00%	175.00%
Risk free interest rate	1.22%
Expected life (in years)	1 month 27 days
Convertible Debenture [Member] | Maximum [Member]
Expected volatility	225.00%	233.00%
Risk free interest rate	1.62%
Expected life (in years)	1 year 6 months

Derivative Liabilities (Detai46

Derivative Liabilities (Details 2) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Derivative Liabilities Details 2
Balance at January 1,	$ 27,930	$ 33,982
Issuance of embedded conversion derivative liabilities	278,425	26,306
Extinguishment due to conversion of convertible debentures	(51,710)	(22,041)
Change in fair value	(27,482)	(10,317)
Total	$ 227,163	$ 27,930

Derivative Liabilities (Detai47

Derivative Liabilities (Details Narrative) - USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Derivative liabilities	$ 227,163	$ 27,930	$ 33,982
Warrant [Member]
Derivative liabilities	$ 7,642	$ 27,930

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - Officer [Member] - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Due to Related Parties	$ 133,535	$ 132,053
Management And Consulting Fees [Member]
Related Party Transaction, Amounts of Transaction	$ 227,080	$ 250,200

Stockholders Deficit (Details N

Stockholders Deficit (Details Narrative) - USD ($)	Nov. 06, 2017	Nov. 02, 2017	Oct. 05, 2017	Oct. 02, 2017	Sep. 07, 2017	Jul. 02, 2017	Mar. 02, 2017	Dec. 13, 2016	Dec. 05, 2016	Oct. 12, 2016	Jun. 09, 2016	May 04, 2016	Jan. 07, 2016	Oct. 17, 2017	Aug. 29, 2017	Jun. 23, 2017	Apr. 20, 2017	Mar. 29, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Jan. 17, 2018
Stock Issued During Period, Shares, New Issues (in Shares)							2,222,222	588,235	980,392	357,143	312,500	250,000						588,240
Proceeds from Issuance or Sale of Equity							$ 200,000	$ 50,000	$ 100,000	$ 37,659	$ 39,283	$ 22,770						$ 76,029
Unit Description							Each unit consisted of one share of common stock and one share purchase warrant exercisable until March 2, 2019	Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.12 per share until December 13, 2017.	Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.15 per share until December 5, 2017.	Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.18 per share until October 12, 2017.	Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.20 per share until June 9, 2017.	Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.15 per share until May 4, 2018.				Each unit will consist of one common share and one share purchase warrant exercisable at $0.35 per share for a period expiring two years from their date of issuance.		Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.25 (Cdn$0.34) per share until March 29, 2018.
Number of units issued															1,875,000	147,059
Price per unit															$ 0.08	$ 0.17
Proceeds from units issued															$ 150,000	$ 25,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)							$ 0.09	$ 0.12	$ 0.15	$ 0.18	$ 0.20	$ 0.15						$ 0.25
Stock Issued During Period, Shares, Issued for Services (in Shares)	1,428,571	625,000	50,000	75,000	49,020	49,020	56,000			50,000				150,000			49,020			479,290	498,801
Stock Issued During Period, Value, Issued for Services	$ 100,000	$ 62,500	$ 4,000	$ 6,000	$ 3,922	$ 4,902	$ 5,640			$ 7,500				$ 12,000			$ 5,392		$ 46,758	$ 60,480	$ 107,944
Deferred compensation charged to operations																			19,592	34,978	$ 70,300
Convertible notes payable																			50,000
Debt Conversion, Original Debt, Amount										6,000									62,500
Derivative liabilities																			51,710
Gain (loss) on settlement of debt										$ 1,500									(39,210)	1,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period													55,556
Proceeds from Stock Options Exercised													$ 5,000
Share issuance costs																				(3,542)
Shares issued for debenture conversion, Shares										512,880
Shares issued for debenture conversion, Amount										$ 79,065									$ 62,500	$ 79,065
Preferred Stock [Member] | Board of Directors [Member] | Subsequent Event [Member]
Preferred stock shares authorized																						10,000,000
Consulting Services [Member]
Stock Issued During Period, Shares, Issued for Services (in Shares)																			49,020
Stock Issued During Period, Value, Issued for Services																			$ 4,902
Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)							$ 0.23
Warrants At 0. 35 Two [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																			$ 0.35
Warrants At 0. 35 One [Member]
Warrants, Expiration Date																			June 23, 2019
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																			$ 0.35
Warrants At 0.18 [Member]
Warrants, Expiration Date							March 2, 2019												March 2, 2019
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)							$ 0.18												$ 0.18

Share Purchase Warrants (Detail

Share Purchase Warrants (Details) - $ / shares	Oct. 06, 2017	May 11, 2017	Apr. 18, 2016	Dec. 31, 2017	Dec. 31, 2016
Weighted average exercise price, Issued	$ 0.08	$ 0.13	$ 0.14
Warrant [Member]
Balance, Number of warrants				4,055,294	1,125,843
Issued				2,419,281	3,076,510
Expired				(2,236,662)	(147,059)
Balance, Number of warrants				4,237,913	4,055,294
Weighted average exercise price begning balance				$ 0.20	$ 0.30
Weighted average exercise price, Issued				0.17	0.17
Weighted average exercise price, Expired				0.22	0.40
Weighted average exercise price ending balance				$ 0.19	$ 0.20

Share Purchase Warrants (Deta51

Share Purchase Warrants (Details 1)	Mar. 02, 2017$ / shares	Dec. 31, 2017$ / sharesshares	Dec. 31, 2017$ / sharesshares	Dec. 31, 2016shares	Dec. 13, 2016$ / shares	Dec. 05, 2016$ / shares	Oct. 12, 2016$ / shares	Jun. 09, 2016$ / shares	May 04, 2016$ / shares	Mar. 29, 2016$ / shares	Dec. 31, 2015shares
Class of Warrant or Right [Line Items]
Exercise price (in Dollars per share) | $ / shares	$ 0.09				$ 0.12	$ 0.15	$ 0.18	$ 0.20	$ 0.15	$ 0.25
Warrants At 0. 20 [Member]
Class of Warrant or Right [Line Items]
Number of warrants outstanding | shares		50,000	50,000
Exercise price (in Dollars per share) | $ / shares		$ 0.20
Expiry date		January 2, 2022
Warrants At 0. 15 Two [Member]
Class of Warrant or Right [Line Items]
Number of warrants outstanding | shares		980,392	980,392
Exercise price (in Dollars per share) | $ / shares		$ 0.15
Expiry date		December 2, 2021
Warrants At 0. 35 One [Member]
Class of Warrant or Right [Line Items]
Number of warrants outstanding | shares		147,059	147,059
Exercise price (in Dollars per share) | $ / shares		$ 0.35
Expiry date		June 23, 2019
Warrants At 0.18 [Member]
Class of Warrant or Right [Line Items]
Number of warrants outstanding | shares		2,222,222	2,222,222
Exercise price (in Dollars per share) | $ / shares	$ 0.18	$ 0.18
Expiry date	March 2, 2019	March 2, 2019
Warrants At 0.34 [Member]
Class of Warrant or Right [Line Items]
Number of warrants outstanding | shares		588,240	588,240
Exercise price (in Dollars per share) | $ / shares			$ 0.34
Expiry date		March 29, 2018
Warrants At 0. 15 One [Member]
Class of Warrant or Right [Line Items]
Number of warrants outstanding | shares		250,000	250,000
Exercise price (in Dollars per share) | $ / shares		$ 0.15
Expiry date		May 4, 2018
Warrant [Member]
Class of Warrant or Right [Line Items]
Number of warrants outstanding | shares		4,237,913	4,237,913	4,055,294							1,125,843

Share Purchase Warrants (Deta52

Share Purchase Warrants (Details Narrative)	12 Months Ended
	Dec. 31, 2017USD ($)shares
Share Purchase Warrants Details Narrative
Warrant issued to purchase common shares | shares	50,000
Fair value of warrants issued | $	$ 2,185
Expected volatility	173.00%
Risk free interest rate	1.14%
Expected life (in years)	3 years

Stock Options (Details)

Stock Options (Details) - USD ($)	Oct. 06, 2017	May 11, 2017	Apr. 18, 2016	Dec. 31, 2017	Dec. 31, 2016
Options Granted	250,000	1,550,000	200,000
Weighted average exercise price granted	$ 0.08	$ 0.13	$ 0.14
Stock Options [Member]
Options begning balance				4,000,000	4,080,556
Options Granted				1,800,000	675,000
Options Expired					(55,556)
Option Cancelled / forfeited				(625,000)	(700,000)
Options ending balance				5,175,000	4,000,000
Weighted average exercise price begning balance				$ 0.16	$ 0.12
Weighted average exercise price granted				0.12	0.13
Weighted average exercise price expired					0.09
Weighted average exercise price Cancelled / forfeited				0.14	0.18
Weighted average exercise price ending balance				$ 0.15	$ 0.16
Aggregate intrinsic value ending balance				$ 11,350

Stock Options (Details 1)

Stock Options (Details 1)	12 Months Ended
	Dec. 31, 2017$ / sharesshares	Dec. 24, 2017	Dec. 31, 2017$ / sharesshares	Dec. 31, 2016shares	Dec. 31, 2015shares
Options 025 [Member]
Range of exercise prices			$ 0.25
Options Outstanding, Number of shares (in Shares) | shares	20,000		20,000
Options Outstanding, Weighted average remaining contractual life	2 years 8 months 12 days
Options Outstanding, Weighted average exercise price			$ 0.25
Options Exercisable, Number of shares (in Shares) | shares	20,000		20,000
Options Exercisable, Weighted average exercise price			$ 0.25
Options 019 [Member]
Range of exercise prices	$ 0.19
Options Outstanding, Number of shares (in Shares) | shares	2,270,000		2,270,000
Options Outstanding, Weighted average remaining contractual life	2 years 8 months 12 days
Options Outstanding, Weighted average exercise price	$ 0.19
Options Exercisable, Number of shares (in Shares) | shares	2,270,000		2,270,000
Options Exercisable, Weighted average exercise price	$ 0.19
Options 016 [Member]
Range of exercise prices	$ 0.16
Options Outstanding, Number of shares (in Shares) | shares	225,000		225,000
Options Outstanding, Weighted average remaining contractual life		3 years 1 month 6 days
Options Outstanding, Weighted average exercise price	$ 0.16
Options Exercisable, Number of shares (in Shares) | shares	112,500		112,500
Options Exercisable, Weighted average exercise price	$ 0.16
Options 013 [Member]
Range of exercise prices	$ 0.13
Options Outstanding, Number of shares (in Shares) | shares	1,425,000		1,425,000
Options Outstanding, Weighted average remaining contractual life	4 years 4 months 28 days
Options Outstanding, Weighted average exercise price	$ 0.13
Options Exercisable, Number of shares (in Shares) | shares	1,100,000		1,100,000
Options Exercisable, Weighted average exercise price	$ 0.13
Options 009 [Member]
Range of exercise prices	$ 0.09
Options Outstanding, Number of shares (in Shares) | shares	910,000		910,000
Options Outstanding, Weighted average remaining contractual life	3 months 18 days
Options Outstanding, Weighted average exercise price	$ 0.09
Options Exercisable, Number of shares (in Shares) | shares	910,000		910,000
Options Exercisable, Weighted average exercise price	$ 0.09
Options 008 [Member]
Range of exercise prices			$ 0.8
Options Outstanding, Number of shares (in Shares) | shares	250,000		250,000
Options Outstanding, Weighted average remaining contractual life	4 years 9 months 18 days
Options Outstanding, Weighted average exercise price			$ 0.8
Options Exercisable, Number of shares (in Shares) | shares	250,000		250,000
Options Exercisable, Weighted average exercise price			$ 0.8
Options 007 [Member]
Range of exercise prices	$ 0.07
Options Outstanding, Number of shares (in Shares) | shares	75,000		75,000
Options Outstanding, Weighted average remaining contractual life	3 months 18 days
Options Outstanding, Weighted average exercise price	$ 0.07
Options Exercisable, Number of shares (in Shares) | shares	75,000		75,000
Options Exercisable, Weighted average exercise price	$ 0.07
Stock Options [Member]
Options Outstanding, Number of shares (in Shares) | shares	5,175,000		5,175,000	4,000,000	4,080,556
Options Outstanding, Weighted average remaining contractual life	2 years 9 months 18 days
Options Outstanding, Weighted average exercise price			$ 0.15
Options Exercisable, Number of shares (in Shares) | shares	4,737,500		4,737,500
Options Exercisable, Weighted average exercise price			$ 0.15

Stock Options (Details 2)

Stock Options (Details 2)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Stock Options Details 2
Expected volatility	136.00%	124.00%
Risk free interest rate	1.80%	1.16%
Expected life (in years)	4 years 9 months 18 days	4 years

Stock Options (Details Narrativ

Stock Options (Details Narrative) - USD ($)

Aug. 09, 2018

May 11, 2018

Nov. 11, 2017

Nov. 01, 2017

Oct. 06, 2017

Aug. 09, 2017

May 11, 2017

Nov. 01, 2016

Oct. 03, 2016

Jul. 21, 2018

Oct. 21, 2017

Jul. 21, 2017

Apr. 18, 2017

Oct. 18, 2016

Jul. 21, 2016

Jul. 18, 2016

Apr. 18, 2016

Dec. 31, 2017

Dec. 31, 2016

Options Granted

250,000

1,550,000

200,000

Weighted average exercise price granted

$ 0.08

$ 0.13

$ 0.14

Option expiry date

Oct. 6, 2022

May 11, 2022

Apr. 18, 2020

Option vested

300,000

50,000

1,150,000

50,000

Option vested percentage

50.00%

50.00%

50.00%

50.00%

50.00%

50.00%

50.00%

25.00%

25.00%

Stock-based compensation

$ 167,772

$ 52,702

Two Consultants [Member]

Options Granted

250,000

Weighted average exercise price granted

$ 0.10

Option expiry date

Oct. 3, 2021

Stock option periodic vested

200,000

Option vested percentage

20.00%

Consultants [Member]

Options Granted

50,000

Weighted average exercise price granted

$ 0.16

Option expiry date

Oct. 3, 2021

EmployeeTwo [Member]

Options Granted

25,000

Weighted average exercise price granted

$ 0.16

Option expiry date

Jul. 21, 2021

EmployeeOne [Member]

Options Granted

150,000

Weighted average exercise price granted

$ 0.16

Option expiry date

Nov. 1, 2020

One Employee And One Consultant [Member]

Option Cancelled

125,000

Segments (Details Narrative)

Segments (Details Narrative)	12 Months Ended
	Dec. 31, 2017
Segments Details Narrative
Number of Reportable Segments	1

Concentration Risk (Details Nar

Concentration Risk (Details Narrative) - Customer Concentration Risk	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Accounts Receivable [Member]
Concentration Risk, Percentage	100.00%	90.00%
Sales Revenue, Net [Member]
Concentration Risk, Percentage	74.00%	66.00%

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Current:
Federal	$ 80,000
State
Foreign
Total Current	80,000
Deferred:
Federal
State
Foreign
Total Deferred
Provision for income taxes	$ 80,000

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Taxes Details 1
Computed tax benefit at federal statutory rate	$ (441,204)	$ (334,703)
Permanent items	(4,016)	78,459
Stock-based compensation	21,635
Incentive stock options	57,042
Conversion feature derivative liability	16,785
Impact of tax law change in rate	720,057
Change in tax rates and true up		(262,355)
Uncertain tax positions	80,000
Impact of difference related to foreign earnings		33,247
Valuation allowance	(370,299)	485,352
Provision for income taxes	$ 80,000

Income Taxes (Details 2)

Income Taxes (Details 2) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Deferred Tax Assets:
Net operating loss carryforwards	$ 1,798,000	$ 2,236,248
Stock-based compensation	1,000
Accounts receivable and other timing differences	121,000
Basis difference in assets and debt	61,000
Equipment		19,367
Share issuance costs		976
Total Deferred Tax Asset	1,981,000	2,256,591
Valuation allowance	(1,981,000)	(2,256,591)
Net Deferred Tax Asset

Income Taxes (Details 3)

Income Taxes (Details 3)	12 Months Ended
	Dec. 31, 2017USD ($)
Beginning balance	$ 6,379
Ending balance	4,481
Federal and state [Member]
Beginning balance
Additions for tax positions related to current year	10,000
Additions for tax positions related to prior years	70,000
Ending balance	$ 80,000

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Net operating loss carryforwards for federal and state income tax	$ 5,299,849	$ 5,954,978
Net operating loss carryforwards for foreign income tax	$ 1,046,761
Foreign income tax, Expiry year	2,032
Open Tax Year	2,006
Unrecognized tax positions	$ 80,000
Deferred tax asset, reduced	$ 720,057
Maximum [Member]
Corporate tax rate, reduced	35.00%
Minimum [Member]
Corporate tax rate, reduced	21.00%

Commitments and Contingencies64

Commitments and Contingencies (Details) - Lease Payments [Member]	Dec. 31, 2017USD ($)
2,018	$ 38,900
2,019	13,100
Total	$ 52,000

Commitments and Contingencies65

Commitments and Contingencies (Details Narrative)	Nov. 06, 2017USD ($)shares	Nov. 02, 2017USD ($)shares	Oct. 05, 2017USD ($)shares	Oct. 02, 2017USD ($)shares	Sep. 07, 2017USD ($)shares	Jul. 02, 2017USD ($)shares	Mar. 02, 2017USD ($)shares	Oct. 12, 2016USD ($)shares	Oct. 17, 2017USD ($)shares	Sep. 30, 2017USD ($)shares	Apr. 20, 2017USD ($)shares	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)shares	Dec. 31, 2015USD ($)shares	Apr. 30, 2017ft²
Operating lease, office space | ft²															2,119
Operating lease, rent expense												$ 47,000	$ 45,000
Common stock, shares issued for services, Shares | shares	1,428,571	625,000	50,000	75,000	49,020	49,020	56,000	50,000	150,000		49,020		479,290	498,801
Common stock, shares issued for services, Value	$ 100,000	$ 62,500	$ 4,000	$ 6,000	$ 3,922	$ 4,902	$ 5,640	$ 7,500	$ 12,000		$ 5,392	$ 46,758	$ 60,480	$ 107,944
Investor Relations Agreement [Member]
Consultant fee, monthly										$ 2,500
Investor Relations Agreement [Member] | First Three Months Services [Member]
Common stock, shares issued for services, Shares | shares										75,000
Common stock, shares issued for services, Value										$ 7,500
Investor Relations Agreement [Member] | Months Four Through Twelve [Member]
Common stock, shares issued for services, Shares | shares										225,000
Common stock, shares issued for services, Value										$ 22,500

Restatement (Details Narrative)

Restatement (Details Narrative)	12 Months Ended
	Dec. 31, 2016USD ($)
Restatement Details Narrative
Adjustment to accumulated deficit (see Note 18)	$ (413,318)

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)	Nov. 02, 2017shares	Oct. 13, 2016shares	Feb. 28, 2018USD ($)shares	Jan. 29, 2018USD ($)	Jan. 22, 2018USD ($)	Jan. 02, 2018shares	Dec. 31, 2017USD ($)$ / sharesshares	Jan. 29, 2018$ / sharesshares	Jan. 22, 2018$ / sharesshares	Dec. 31, 2016USD ($)$ / sharesshares
Common Stock, Shares issued							39,214,517			32,389,585
Common shares, par value | $ / shares							$ 0.001			$ 0.001
Common stock, shares issued for conversion of debt, Shares	625,000	512,880
Accrued interest | $							$ 49,696			$ 39,035
Subsequent Event [Member]
Common Stock, Shares issued								5,000,000	2,777,778
Common shares, par value | $ / shares								$ 0.08	$ 0.072
Proceeds from common Stock | $				$ 400,000	$ 200,000
Common stock, shares issued for conversion of debt, Shares			806,916
Common stock, shares issued for conversion of debt, Value | $			$ 50,000
Accrued interest | $			$ 6,000
Common stock, shares issued to consultants for services						274,020
Subsequent Event [Member] | February and March 2018 [Member]
Common stock, shares issued for conversion of debt, Shares							554,954
Common stock, shares issued for conversion of debt, Value | $							$ 23,250